From quality-led differentiation to digital alignment and regional strategy, CDMOs are redefining how they compete in a more constrained, complex outsourcing landscape.
In this Pharma Matters Q&A, Anshul Gupte, PhD, RAC Drugs, VP of Pharmaceutical Development at PCI Pharma Services, provides updates on the expansions in Bedford and León, Spain, and talks about the importance and advantages of being able to offer services across multiple modalities.
Overcoming common challenges with today’s biologics, such as developing devices
for high-concentration subcutaneous administration, can accelerate the launch of novel products, reduce risks, and enhance commercial success.
From legacy therapeutics to next-generation GLP-1s, advances in synthesis, analysis, and regulation are reshaping how peptide drugs are developed and brought to market
As demands for aseptic manufacturing increase, partnerships among solutions providers will
become key to ensuring safe, versatile and optimized drug containment.
Reframing pharmaceutical production around process stability, real-time quality assurance, and regulatory alignment in the era of continuous manufacturing.
Contract packaging demands flexibility, efficiency, and control. At Praxis, we deliver all three through the innovative, cost effective application of manual labor and the skillful use of automated and custom packaging equipment. We've been doing so for about a quarter century. Our OTC/Rx pharmaceutical, consumer products, and medical device customers choose us for four reasons: a relentless focus on compliance, astonishing speed-to-market, unyielding accountability, and significant category experience. At Praxis, we don't just deliver innovative, turnkey packaging solutions. We provide them while exceeding our customers' expectations, while managing their critical deadlines, and while upholding rigorous regulatory and quality standards. You could call it agility; we call it Managed Rapid Response, and here at Praxis, it's at the heart of what we do. Upholding standards is so deeply engrained at Praxis that, since the company was formed, we've had exactly zero recalls.
As a premier, independently owned CDMO with over 65+ years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer clients tailored and versatile solutions to help them bring their products to market.
